An Open-label Study of GC012F in Rheumatoid Arthritis.

NCT07315503 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

NOT_YET_RECRUITING

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: LD and GC012F CAR-T Cell Injection
DRUG: GC012F CAR-T Cell Injection

Sponsor

Institute of Hematology & Blood Diseases Hospital, China